Search Results
FDA approval of anifrolumab for SLE | Eric Morand
Should you treat Lupus patients with Anifrolumab?
RheumNow Podcast – Saphnelo (Anifrolumab) Approved for Lupus (8.6.2021)
Anifrolumab and Oral Deucravacitinib shows promise in patients with lupus
Anifrolumab efficacy and safety by type I IFNGS and clinical subgroups in patients with SLE
Professor Eric Morand FAHMS - 2022 Fellow
A Novel Treatment Response Measurement Tool for Lupus
TULIP Trials in Lupus: Dr. Mike Putman
LRA Global Team Science Award - Dr. Eric Morand
Dr Sudhakar Tumuluri | SAPHNELO® (anifrolumab-fnia) Clinical Data
2021 ACR - New Analyses Highlights Disease Activity Reduction in Lupus Patients
Dosing and Administration | SAPHNELO® (anifrolumab-fnia)
